Stock ELEV ELEVATION ONCOLOGY, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Elevation Oncology, Inc.

Equities

ELEV

US28623U1016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
3.84 USD +4.07% Intraday chart for Elevation Oncology, Inc. +6.37% +615.08%
May. 14 Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target MT
May. 02 Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ELEVATION ONCOLOGY, INC. Stock Elevation Oncology, Inc.
 210M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 23.4B -
ARGENX SE Stock argenx SE
 21.78B -
GENMAB A/S Stock Genmab A/S
 18.09B
  1. Stock Market
  2. Equities
  3. ELEV Stock
  4. Charts Elevation Oncology, Inc.
  5. Sector Chart